Empowering AOA members to become advocates for their profession.​

Congress’ Medicare vision efforts fizzle, 10% pay cuts still loom

A Medicare vision benefit expansion was cut from the Build Back Better Act, but now advocates shift focus to avoiding nearly 10% cuts to Medicare reimbursement on Jan. 1, 2022.

AOA and state associations target plan abuses

Payer Advocacy Summit gathers “all-in” doctors from every state as AOA legal team takes next steps in fight against anti-doctor and anti-patient policies.

Optometry’s advocates going FAR beyond the call

Do you know your AOA Federal Advocacy Representative? Connect with the AOA-FAR in your state and learn how to engage AOA’s federal advocacy.

AOA, AFOS make case to Department of Veterans Affairs for access-boosting national practice standards

AOA President Robert C. Layman, O.D., underscores AFOS and AOA support for national practice standards that allow doctors of optometry to operate “at the top of their license and training” and don’t limit veterans’ access to essential eye and vision care.

Fight for Optometry

The AOA is the only advocate for optometry. Discover how you can help optometry keep a seat at the table whenever and wherever health care policy decisions are being made.
New York gains oral medication prescribing authority

The Empire State rounds out the list of states permitting optometry’s oral medication prescribing for ocular diseases, capping a year of historic scope wins for optometry’s advocates.

Nearly 10% Medicare pay cuts loom without Congress’ action

Congressional action is needed to stave off a trio of pay cuts totaling almost 10% of Medicare physicians’ reimbursement. Here’s how you can help.

Medicare expansion: The long road to here and now

Current debate on Medicare benefits expansion offers a moment to look back on similar points in time when federal action intersected the profession—and how the AOA advocated for you.

California amends optometry’s approved treatments, medications and testing

The scope victories eliminate some prior drug and treatment restrictions while also authorizing expanded testing, as well as COVID-19 vaccine administration.

Be a better negotiator on payer issues

Register now for the virtual AOA Payer Advocacy Summit, Nov. 15-16.

Mere commoditization

Contact lens “gray markets,” deregulation pose real concerns for our patients’ health.